ASX Earnings Rallies Prove Fleeting for Many Stocks

The August ASX reporting season revealed a perplexing trend: many companies rallied significantly on better-than-expected earnings, only to see these gains evaporate in subsequent days. Matthew Ross, Goldman Sachs’ Australian equity strategist, noted almost half of S&P/ASX 200 companies experienced a 5 per cent movement on their results—a record high, well above the 28 per cent long-term average. This heightened volatility is attributed to the increasing influence of passive investing, pod shops, and quant funds, which can trigger outsized share price reactions to minor beats or misses.
Ross expressed bewilderment at why many companies surrendered their initial earnings-driven gains by August’s end, calling it “very unusual.” Historically, stocks beating expectations tend to outperform for one to two months. Medical software imaging group Pro Medicus, for instance, jumped 11.9 per cent on August 18 but has since fallen over 12 per cent. Financial services group MA Financial rocketed 18 per cent, then lost nearly 28 per cent. Buy now, pay later giant Zip and Car Group, which owns the popular vehicle listings platform Carsales, saw similar initial surges followed by significant declines. ARB Corporation, a manufacturer of four-wheel drive accessories, and fast fashion jewellery chain Lovisa also experienced quickly reversed post-earnings rallies.
The prominent outlier was blood plasma giant CSL, which soared 17.3 per cent on August 18 and has since risen another 10 per cent, contributing to a record 19.3 per cent return for the healthcare sector. Conversely, banks recorded their worst month since June 2022, falling 9.3 per cent amid slowing credit growth and housing concerns. Morgan Stanley equity strategist Chris Nicol affirmed that merely meeting earnings expectations is no longer sufficient on the ASX. He noted Australia avoided a broad earnings meltdown, but the outlook remains uneven with downside risks. Nicol concluded share price performance increasingly reflects quality, sustainable forward earnings, credible guidance, valuation support, and capital allocation discipline.